Alkermes Pharma Ireland Ltd |

Employees: > 250

About Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.

Our Graduate Programme

Based in Athlone, our graduate programme is 2 years in duration and offers a great opportunity to put what you have learned through your undergraduate into practice and carve the path to your future career. Our programme focuses on rotating through different departments in Alkermes, getting hands on experience and exposure to many different facets of a Biopharmaceutical R&D and Manufacturing site. Some of the rotations include Engineering, Information Technology, Manufacturing, Quality Assurance, Validation, Regulatory Supply Chain. Alkermes offers excellent opportunities for career development in an environment that is science-driven, intellectual, inclusive and collaborative. Participants in the programme are eligible to receive a competitive salary, healthcare, pension and other benefits.

Your learning journey continues with a variety of training and development programs on your personal brand, communication, people management and technical courses which lends to our culture of continuous learning, empowering individuals to drive their own growth and development. This programme utilises a blended learning approach.

Graduates are encouraged to participate in engagement initiatives (Corporate Social Responsibility (CSR), Diversity Inclusion & Belonging (DIB) and Wellbeing as part of their cultural learning.

If you are a recent graduate from science, engineering or business, are curious, hard-working, persistent, collaborative, and committed to supporting the development of innovative medicines for patients, families and communities, then the Alkermes Graduate Programme is for you.

More about us

Our R&D strategy is focused on identifying targets with strong biological rationale and applying our advanced small molecule drug development and protein engineering capabilities to create new molecular entities with the potential to address important unmet patient needs in the fields of neuroscience. Our approach is further rooted in a thoughtful and patient-centric focus on real-world challenges and in disciplined application of pre-determined stage-gates and defined success criteria throughout the development process.

Alkermes employees are united in our purpose to pursue Great Science with Deep Compassion to make a Real Impact in the lives of the patients, families and communities that we serve. Our Values – developed in collaboration with our employees – outline how we work: Collaboration, with Respect for Each Voice and an Unwavering Commitment to achieve our Purpose.

Alkermes is committed to diversity, inclusion and belonging (DIB) in various aspects of our business. We strive to foster an environment of equality and compassion, where all voices are respected and valued. It is important to our mission and our ethos as an organization that we attract and retain diverse candidates and perspectives.